Tezalon 40 mg (Telmisartan)

Adult dose

1. Essential Hypertension Telmisartan should be administered orally at a dose of 40 mg once daily with water, and can be taken without regard to meals. For some patients, a dose of 20 mg once daily may be effective. If necessary, the dose can be increased to 80 mg once daily. When increasing the dose, maximum blood pressure-lowering effects are expected to be seen 4 to 8 weeks after treatment initiation. 2. Reduction of Cardiovascular Disease Risk This medication is recommended to be taken orally at a dose of 80 mg once daily with water, and can be taken without regard to meals. The effectiveness of reducing the morbidity and mortality of cardiovascular disease at doses less than 80 mg is not known. If this medication is used for the purpose of reducing cardiovascular disease risk, blood pressure monitoring is recommended, and appropriate adjustments of antihypertensive medication may be required. ○ Patients with Liver Impairment Patients with mild to moderate liver impairment should be administered with caution and should not exceed a dose of 40 mg once daily.

This medication can cause serious harm to the fetus and newborn, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used by those who are allergic to this medicine or its components, pregnant or breastfeeding women, patients with severe liver impairment or biliary obstruction, hereditary angioedema patients, and those with diabetes or severe kidney impairment. Elderly patients, those with hyperkalemia, liver impairment, heart valve disease, ischemic heart disease, gastrointestinal disease, renal vascular hypertension, and severe kidney impairment should use this medication with caution, and co-administration with other RAAS agents is not recommended. During treatment, various adverse reactions may occur, including infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, neurological symptoms, vision abnormalities, heart and vascular problems, breathing difficulties, liver dysfunction, skin rash, muscle pain, and kidney dysfunction, so immediate consultation with a doctor is required if symptoms arise. In particular, if blood pressure drops suddenly, dizziness or fainting may occur, so appropriate measures such as lying the patient down and administering saline if necessary should be taken. Patients with impaired kidney function should have regular checks of serum potassium and creatinine levels, and those with hypovolemia or sodium depletion should correct these prior to administration to avoid the risk of hypotension. This medication may increase blood pressure-lowering effects when taken with other antihypertensive drugs, so caution is advised, and there may be interactions with some medications requiring consultation with a doctor before co-administration. Women who are pregnant or breastfeeding should preferably avoid this medication, and those planning to become pregnant should also avoid use. It is not recommended for children under 18 years as safety and efficacy are not established. Elderly patients should be administered with caution due to the risk of complications such as strokes from excessive lowering of blood pressure. In case of overdose, symptoms may include hypotension, abnormal heart rates, dizziness, and kidney impairment, so immediate medical assistance should be sought, and care must be taken as the drug is not removed by dialysis. This medicine should be kept out of reach of children and the packaging should not be opened until just before use. When driving or operating machinery, caution should be taken due to the possibility of dizziness or fainting.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, cough accompanied by fever and breathing abnormalities, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination changes

Mild side effects

• Upper respiratory infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication may be sensitive to air and moisture, so it must be stored in a sealed container. Additionally, it should be kept at a temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way helps maintain the efficacy of the medication.

Appearance

White oblong tablet

Package unit

30 tablets/box [(10 tablets/PTP packaging x 3)], 30 tablets/bottle